NC LES 01 · 2026/27

PCQOF — Proactive Care Quality & Outcomes Framework

Previously known as ICCQ

Last update

1 July 2026

Data source

Clinical system

Refresh

Weekly · live

Next refresh

Auto · weekly

Indicator type

Date window

PCN & Practice

View as at

KPIs on target

2/23

21 below · 10 monitoring

Performance

29.3%

22 payment KPIs

Highest performing

CVD02

70.8% · target 64% · +6.8%

6,331 / 8,948

Lowest performing

CVD04

0% · target 92% · -92%

0 / 1,424

Most improved

—

Needs 2+ uploads

On target (2)Near target (2)Below target (22)No data (7)Mon= Monitoring only — no payment threshold

Indicator⇅	Target⇅	Target activity⇅	Performance %⇅	Activity⇅	Population⇅	Shortfall⇅	Status	Q1 %	Q2 %
Complex Care
CC01Sociofunctional assessment done (FY)▸	90%	3,199	26.2%	930	3,554	2,269	Below	6.6%	13.1%
CC02Carer info recorded (FY)▸	90%	3,199	27.6%	981	3,554	2,218	Below	6.9%	13.8%
CC03UCP care plan [PAY]Mon▸	Monitoring	—	—	43	—	—	Monitoring	—	—
CC04Comprehensive Medication Review (FY)Mon▸	80%	2,844	24.6%	875	3,554	1,969	Below	6.2%	12.3%
CC05Prognosis discussed FYMon▸	50%	803	11.6%	187	1,606	616	Below	2.9%	5.8%
CC06Anticipatory care planning FYMon▸	50%	803	9.3%	150	1,606	653	Below	2.3%	4.7%
Diabetes
DM01T2DM 8 Care Processes Completed (FY)▸	78%	17,109	22%	4,828	21,934	12,281	Below	5.5%	11%
DM02Digital Retinal Screening (FY)▸	75%	16,451	38%	8,336	21,934	8,115	Below	9.5%	19%
DM03T2DM Triple Target Completed (FY)▸	43%	8,757	14.4%	2,941	20,365	5,816	Below	3.6%	7.2%
Mental Health
MH01Antipsychotic monitoring (FY)▸	70%	1,041	13.9%	206	1,486	835	Below	3.5%	7%
MH02MH Depot Q1 2026-2027▸	NIS	—	—	97	—	—	No data	—	—
Respiratory
RSP01COPD Annual Review [NIS]Mon▸	Monitoring	—	4.4%	133	3,050	—	Monitoring	1.1%	2.2%
RSP02MRC 3+ Ref to Pul Rehab (01/04/24 - 31/03/27)▸	65%	917	62.1%	875	1,410	42	Near	15.5%	31.1%
Cardiovascular
CVD01Primary Prevention Statins (FY)▸	70%	16,698	74.4%	17,758	23,853	Met	Met	18.6%	37.2%
CVD02Secondary Prevention Statins (FY)▸	64%	5,727	70.8%	6,331	8,948	Met	Met	17.7%	35.4%
CVD03CVD BP <140/90 (FY)▸	80%	6,631	37.2%	3,085	8,288	3,546	Below	9.3%	18.6%
CVD04AF patients on anticoagulants (FY)▸	92%	1,311	0%	—	1,424	1,311	Below	0%	0%
Renal
CKD01CKD BP <140/90 (FY)▸	65%	3,867	33.5%	1,991	5,949	1,876	Below	8.4%	16.8%
CKD02CKD ACR >70 with BP <130/80 (FY) [NIS]Mon▸	Monitoring	—	21.7%	1,575	7,265	—	Monitoring	5.4%	10.9%
CKD03CKD Proteinuria with ACEi/ARBs (FY)▸	81%	1,325	0%	—	1,635	1,325	Below	0%	0%
CKD04CKD G2/A3 or above with ACR urine (FY)▸	73%	6,022	24.1%	1,985	8,249	4,037	Below	6%	12.1%
CKD05CKD stages 1-5 recorded (FY)▸	19%	1,051	6.5%	360	5,531	691	Below	1.6%	3.3%
Care Planning
CP02Smoking Intervention (FY)▸	90%	8,096	46.2%	4,158	8,995	3,938	Below	11.6%	23.1%
CP03Flu Vaccination (FY)Mon▸	74%	33,283	0%	—	44,976	33,283	Below	0%	0%
CP04Care Planning completed (FY)▸	70–75%	40,591	17.6%	9,534	54,121	31,057	Below	4.4%	8.8%
CP05Asthma Children Care Planning completed (FY)▸	72%	2,068	22.4%	643	2,872	1,425	Below	5.6%	11.2%
CP06Asthma only Adults Care Planning completed (FY)▸	70%	6,380	16.4%	1,495	9,113	4,885	Below	4.1%	8.2%
CP07Wider Determinants Enquiry Recorded (Apr 2025-Mar 2027)▸	80%	43,603	68.7%	37,455	54,503	6,148	Near	17.2%	34.4%
NDPP
NDPP1bValid Referrals to NDPP (FY)Mon▸	Monitoring	—	—	83	—	—	Monitoring	—	—
ADHD
ADHD01ADHD First Review DoneMon▸	Monitoring	—	17.6%	305	1,737	—	Monitoring	4.4%	8.8%
ADHD02ADHD Second Review DoneMon▸	Monitoring	—	0%	—	1,737	—	Monitoring	0%	0%
High Risk CVD
HRR1High Risk CVD Annual Review done (15m)▸	70%	2,477	16%	566	3,538	1,911	Below	4%	8%
HRR2High Risk CVD prescribe statin and lifestyle advice▸	60%	2,123	6.5%	229	3,538	1,894	Below	1.6%	3.3%

Data as of 1 July 2026 · Clinical system · Refreshed weekly